Tax positions must meet a “more likely than not” recognition threshold at the effective date to be recognized. At December 31, 2014 and 2013, the Company did not have any uncertain tax positions. No interest and penalties related to uncertain tax positions were accrued at December 31, 2014 and 2013.

       We did not record an income tax benefit or provision for the year ended December 31, 2014.

        Significant items making up the deferred tax assets and deferred tax liabilities as of December 31, 2014 and December 31, 2013 are as follows:

A valuation allowance is established if it is more likely than not that all or a portion of the deferred tax asset will not be realized. Accordingly, a valuation allowance was established in 2014 and 2013 for the full amount of our deferred tax assets due to the uncertainty of realization. We believe based on our projection of future taxable operating income for the foreseeable future, it is more likely than not that we will not be able to realize the benefit of the deferred tax asset at December 31, 2014.

We have net operating loss carry-forwards for federal income tax purposes of $22,260,000 as of December 31, 2014. Included in these numbers are loss carry-forwards that were obtained through the acquisition of BioSeq, Inc. and are subject to Section 382 NOL limitations. These net operating loss carry-forwards expire at various dates from 2015 through 2035.

We had net operating loss carry-forwards for state income tax purposes of approximately $16,496,000 at December 31, 2014. These net operating loss carry-forwards expire at various dates from 2015 through 2034.

       We have research and development tax credit carryforwards for federal income tax purposes of approximately $1,019,000 as of December 31, 2014 and research and development tax credit carryforwards for state income tax purposes of approximately $165,000 as of December 31, 2014. The federal credit carryforwards expire at various dates from 2015 through 2034.  The state credit carryforwards expire at various dates from 2014 through 2028.

        In addition, we have federal alternative minimum tax credit carryforwards for federal income tax purposes of approximately $217,000 as of December 31, 2014.  These credits do not expire.

Our effective income tax (benefit) provision rate was different than the statutory federal income tax (benefit) provision rate as follows for the years ended December 31: